4D Medicine

4D Medicine Limited, founded in 2018 in Birmingham, UK, focuses on the design and development of bioabsorbable medical devices.4D Medicine's principal product offering is the innovative 4Degra® polymer, a patented bioabsorbable material developed by Professor Andrew Dove after 15 years of research. This implantable medical polymer is engineered for the design and development of novel bioabsorbable medical devices that can be manufactured using advanced 3D printing techniques, allowing for high resolution and flexibility in dimensional scale. The end use cases that 4D Medicine aims to address include improving surgical outcomes and enhancing patient quality of life globally.4D Medicine generates revenue primarily through partnerships with healthcare institutions and medical device manufacturers, focusing on B2B transactions. These collaborations may involve bulk procurement agreements for the supply of their flagship product, 4Degra®, and potentially other related bioabsorbable medical devices tailored to specific surgical needs. The transaction structure typically includes negotiated contracts that define pricing and delivery terms, ensuring a steady flow of products to clients. Plans for future growth also include the introduction of additional products designed to meet specific surgical needs and expanding into new markets in North America and Asia by 2025.

1. Series A

   Jul 25, 2024

   Amount

   $4.4M

   Investors

   Locked